Criminal or bystander: imatinib and second primary malignancy in GIST patients

被引：8
作者：
Kanda, Tatsuo [1 ]
机构：
[1] Sanjo Gen Hosp, Sanjo City, Niigata 9550055, Japan
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2013年 / 25卷 / 05期
关键词：
GASTROINTESTINAL STROMAL TUMORS; NEOPLASMS; COEXISTENCE; KIT;
D O I：
10.3978/j.issn.1000-9604.2013.10.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：490 / 492
页数：3
相关论文
共 50 条
[21]   Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib [J].
Italiano, Antoine ;
Cioffi, Angela ;
Coco, Paola ;
Maki, Robert G. ;
Schoffski, Patrick ;
Rutkowski, Piotr ;
Le Cesne, Axel ;
Duffaud, Florence ;
Adenis, Antoine ;
Isambert, Nicolas ;
Bompas, Emmanuelle ;
Blay, Jean-Yves ;
Casali, Paolo ;
Keohan, Mary Louise ;
Toulmonde, Maud ;
Antonescu, Cristina R. ;
Debiec-Rychter, Maria ;
Coindre, Jean-Michel ;
Bui, Binh .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) :1551-1559
[22]   Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis [J].
Vincenzi, Bruno ;
Nannini, Margherita ;
Fumagalli, Elena ;
Bronte, Giuseppe ;
Frezza, Anna Maria ;
De Lisi, Delia ;
Ceruso, Mariella Spalato ;
Santini, Daniele ;
Badalamenti, Giuseppe ;
Pantaleo, Maria Abbondanza ;
Russo, Antonio ;
Dei Tos, AngeloPaolo ;
Casali, Paolo ;
Tonini, Giuseppe .
ONCOTARGET, 2016, 7 (43) :69412-69419
[23]   A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients [J].
Eechoute, Karel ;
Fransson, Martin N. ;
Reyners, An K. ;
de Jong, Floris A. ;
Sparreboom, Alex ;
van der Graaf, Winette T. A. ;
Friberg, Lena E. ;
Schiavon, Gaia ;
Wiemer, Erik A. C. ;
Verweij, Jaap ;
Loos, Walter J. ;
Mathijssen, Ron H. J. ;
De Giorgi, Ugo .
CLINICAL CANCER RESEARCH, 2012, 18 (20) :5780-5787
[24]   Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability [J].
Kim, Kyu-pyo ;
Ryu, Min-Hee ;
Yoo, Changhoon ;
Ryoo, Baek-Yeol ;
Choi, Dae Ro ;
Chang, Heung Moon ;
Lee, Jae-Lyun ;
Beck, Mo Youl ;
Kim, Tae Won ;
Kang, Yoon-Koo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) :285-291
[25]   Surgical Management in Metastatic Gastrointestinal Stromal Tumor (GIST) Patients After Imatinib Mesylate Treatment [J].
Yeh, Chun-Nan ;
Chen, Tsung-Wen ;
Tseng, Jeng-Hwei ;
Liu, Yu-Yin ;
Wang, Shang-Yu ;
Tsai, Chun-Yi ;
Chiang, Kun-Chun ;
Hwang, Tsann-Long ;
Jan, Yi-Yin ;
Chen, Miin-Fu .
JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (06) :599-603
[26]   An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy [J].
Nikolaos Vassos ;
Abbas Agaimy ;
Anne Schlabrakowski ;
Werner Hohenberger ;
Regine Schneider-Stock ;
Roland S. Croner .
Virchows Archiv, 2011, 458 :363-369
[27]   Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure [J].
Bins, Sander ;
Eechoute, Karel ;
Kloth, Jacqueline S. L. ;
de Man, Femke M. ;
Oosten, Astrid W. ;
de Bruijn, Peter ;
Sleijfer, Stefan ;
Mathijssen, Ron H. J. .
CLINICAL PHARMACOKINETICS, 2017, 56 (03) :305-310
[28]   Long-Surviving Patients with Recurrent GIST after Receiving Cytoreductive Surgery with Imatinib Therapy [J].
Choi, Won Hyuk ;
Kim, Sungsoo ;
Hyung, Woo Jin ;
Yu, Jeong Sik ;
Park, Chan Il ;
Choi, Seung Ho ;
Noh, Sung Hoon .
YONSEI MEDICAL JOURNAL, 2009, 50 (03) :437-440
[29]   An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy [J].
Vassos, Nikolaos ;
Agaimy, Abbas ;
Schlabrakowski, Anne ;
Hohenberger, Werner ;
Schneider-Stock, Regine ;
Croner, Roland S. .
VIRCHOWS ARCHIV, 2011, 458 (03) :363-369
[30]   Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018 [J].
Wang, Jing ;
Lv, Chenglan ;
Zhou, Min ;
Xu, Jing-Yan ;
Chen, Bing ;
Wan, Yuan .
CANCERS, 2022, 14 (19)
12345